Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chandler Robinson currently holds 93,403 shares of Monopar Therapeutics (MNPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chandler Robinson has been a net seller of MNPR stock. They have purchased $0 and sold $672.0K worth of shares.
Chandler Robinson's most recent insider trade was on Jun 30, 2026, when they sold 12,873 shares at $0.00 per share.
Chandler Robinson serves as Executive at Monopar Therapeutics (MNPR). They have executed 54 insider transactions totaling $672.0K over their tenure at the company.
Chandler Robinson holds the position of Executive at Monopar Therapeutics, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Chandler Robinson has shown a selling trading pattern, with $0 in total purchases and $672.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Chandler Robinson was on Jul 14, 2025, when they sold $672.0K worth of MNPR shares. This transaction involved 16,800 shares at $40.00 per share.
Chandler Robinson currently owns 93,403 shares of Monopar Therapeutics (MNPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chandler Robinson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chandler Robinson has 54 Form 4 filings on record as an insider at Monopar Therapeutics.
Set alerts for Chandler Robinson and 40,000+ other insiders.